Nicholas A Plaxton1, David C Brandon2, Amanda S Corey3, Chester E Harrison4, A Tuba Karagulle Kendi3, Raghuveer K Halkar3, Bruce J Barron2. 1. 1 Nuclear Medicine Department, Bay Pines Veterans Affairs Medical Center, 10000 Bay Pines Blvd, Second Fl, Rm 2C-120, Bay Pines, FL 33744. 2. 2 Nuclear Medicine Department, Atlanta Veterans Affairs Medical Center, Decatur, GA. 3. 3 Department of Radiology and Imaging Sciences, Emory University Hospital, Atlanta, GA. 4. 4 Clinical Radiologists SC, Springfield, IL.
Abstract
OBJECTIVE: This image-based article illustrates the anatomic regions of squamous cell carcinomas of the head and neck and describes the metastatic pathways in and TNM staging for each region. Both the role and limitations of FDG PET/CT in imaging such cancers are discussed, and cases exemplifying these issues are reported. Also included is a discussion of the use of FDG PET/CT to monitor the response of squamous cell carcinomas of the head and neck to therapy, in addition to a brief comparison of PET/CT with such traditional imaging modalities as CT, MRI, and ultrasound. CONCLUSION: Understanding the characteristics of squamous cell carcinoma of the head and neck, as imaged by FDG PET/CT, is crucial for determining treatment strategy, because it helps to avoid incorrect staging and also provides an accurate assessment of treatment response.
OBJECTIVE: This image-based article illustrates the anatomic regions of squamous cell carcinomas of the head and neck and describes the metastatic pathways in and TNM staging for each region. Both the role and limitations of FDG PET/CT in imaging such cancers are discussed, and cases exemplifying these issues are reported. Also included is a discussion of the use of FDG PET/CT to monitor the response of squamous cell carcinomas of the head and neck to therapy, in addition to a brief comparison of PET/CT with such traditional imaging modalities as CT, MRI, and ultrasound. CONCLUSION: Understanding the characteristics of squamous cell carcinoma of the head and neck, as imaged by FDG PET/CT, is crucial for determining treatment strategy, because it helps to avoid incorrect staging and also provides an accurate assessment of treatment response.
Entities:
Keywords:
FDG PET/CT; TNM staging; head and neck squamous cell carcinoma; metastatic pathways; treatment response
Authors: Clemens Kratochwil; Paul Flechsig; Thomas Lindner; Labidi Abderrahim; Annette Altmann; Walter Mier; Sebastian Adeberg; Hendrik Rathke; Manuel Röhrich; Hauke Winter; Peter K Plinkert; Frederik Marme; Matthias Lang; Hans-Ulrich Kauczor; Dirk Jäger; Jürgen Debus; Uwe Haberkorn; Frederik L Giesel Journal: J Nucl Med Date: 2019-04-06 Impact factor: 10.057
Authors: Christian Linz; Roman C Brands; Olivia Kertels; Alexander Dierks; Joachim Brumberg; Elena Gerhard-Hartmann; Stefan Hartmann; Andreas Schirbel; Sebastian Serfling; Yingjun Zhi; Andreas K Buck; Alexander Kübler; Julian Hohm; Constantin Lapa; Malte Kircher Journal: Eur J Nucl Med Mol Imaging Date: 2021-05-29 Impact factor: 9.236